Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients.

The pharmacokinetics of cidofovir (HPMPC; (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine) were examined at five dose levels in three phase I/II studies in a total of 42 human immunodeficiency virus-infected patients (with or without asymptomatic cytomegalovirus infection). Levels of cidofovir...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Cundy, K C, Petty, B G, Flaherty, J, Fisher, P E, Polis, M A, Wachsman, M, Lietman, P S, Lalezari, J P, Hitchcock, M J, Jaffe, H S
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1995
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162721/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7574510/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.6.1247
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!